Hepatology
From the Journals
Initial HCV test results are false positive in almost half of general population
Nearly half of patients in the general population who test positive for hepatitis C virus (HCV) do not have the disease.
From the Journals
AGA Guideline: Acute liver failure
Physicians should avoid routinely testing patients with acute liver failure for Wilson’s disease unless there is “high clinical suspicion” for the...
From the Journals
VIDEO: Sofosbuvir with velpatasvir beat other HCV GT3 regimens
Regimens containing sofosbuvir and velpatasvir were most effective for treating both cirrhotic and noncirrhotic genotype 3 hepatitis C virus...
From the Journals
Prominent clinical guidelines fall short of conflict of interest standards
Two recent clinical practice guidelines – one for cholesterol management and another for treatment of chronic hepatitis C – did not meet the...
From the Journals
Half of newly detected antimicrobial antibodies do not lead to PBC
Nearly half of newly detected antimitochondrial antibodies (AMAs) in clinical practice do not lead to a diagnosis of primary biliary cholangitis (...
From the Journals
Hepatitis outlook: December 2016
Drug-drug interactions between direct-acting antivirals and antiretroviral therapy are frequently found among HIV/HCV-coinfected patients. Read...
Conference Coverage
Meta-analysis compares infliximab with tacrolimus in ulcerative colitis
ORLANDO – Researchers compare and contrast infliximab with tacrolimus for safety, efficacy, and helping patients with active ulcerative colitis...
Conference Coverage
Lysosomal acid lipase replacement corrects rare genetic cause of liver failure, atherosclerosis
BOSTON
Article
VIDEO: NAFLD costing U.S. $290 billion annually
BOSTON - A sophisticated mathematical analysis shows that nonalcoholic fatty liver disease is costing the United States over $290 billion annually...
From the Journals
Hepatitis Outlook: November 2016
Baseline hepatitis B core antibody predicts treatment response in chronic HBV patients receiving long-term entecavir, according to a recent study...
Video
VIDEO: Angiogenesis has a role to play in NASH and NAFLD
BOSTON